-
Product Insights
NewHyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hyaluronic Acid Fillers Pipeline Market Report Overview Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the...
-
Product Insights
NewBreast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Breast Implants Pipeline Market Report Overview Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments...
-
Analyst Opinions
NewAI Compute – How Chips Drive Next Industrial Leap
AI Chips Trend Analysis Report Overview GlobalData's "AI Compute: How Chips Drive Next Industrial Leap," innovation radar report explores the transformative impact of semiconductor chip innovations, particularly AI chips, across various industries such as healthcare, telecom, and energy & utilities. The report illuminates how advanced chips are enhancing computational power, enabling improved analytics, and driving automation. By reshaping industrial processes, these technologies are boosting efficiency and fostering innovation. The “AI Compute” report provides strategic insights to help businesses capitalize on...
-
Innovation Ranking
NewInnovation Ranking – Adicet Bio Inc
Adicet Bio Inc (Adicet Bio), formerly resTORbio Inc, is a biotechnology company. The company is engaged in developing allogeneic gamma delta T cell therapies for addressing the unmet medical need of solid tumors and hematological cancers. Adicet Bio's pre-clinical pipeline includes ADI-001, a CD20 CAR-T cell therapy candidate for the treatment of non-hodgkin's lymphoma; and ADI-002, a GPC3-targeting chimeric antigen receptor (CAR) for the treatment of hepatocellular carcinoma. It is also advancing the ADI-00x program for multiple solid tumors. Adicet...
-
Innovation Ranking
NewInnovation Ranking – Shanghai Kehua Bio-engineering Co Ltd
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes COVID-19 products, immunologic diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing) products. It also offers comprehensive services for regional medical communities. KHB established R&D centers and production bases in many countries and regions including Italy. The company has sales support facilities in major cities in China and markets products in China...
-
Innovation Ranking
NewInnovation Ranking – IVERIC bio Inc
IVERIC bio Inc (IVERIC bio), formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It provides Fovista, an anti-platelet-derived growth factor (PDGF). IVERIC bio offers gene therapy research programs, dry age-related macular degeneration and ophthalmic orphan programs. The company seeks to collaborate with companies and academic institutions to develop gene therapy product...
-
Innovation Ranking
NewInnovation Ranking – Bio-Path Holdings Inc
Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen and BP1002 (Liposomal Bcl2). Its prexigebersen, is developed for the treatment of Acute Myeloid Leukemia (AML) and solid tumors. Bio-Path's BP1002 (Liposomal Bcl2) is used for the treatment of lymphoma, leukemia, colon, prostate and breast cancers, among others. The company's proprietary liposomal delivery and antisense...
-
Innovation Ranking
NewInnovation Ranking – Gossamer Bio Inc
Gossamer Bio Inc (Gossamer Bio) is a biopharmaceutical company that involves discovering, developing, and commercializing medicines for the disease areas of immunology, inflammation, and oncology. The company’s product portfolio includes GB002, for pulmonary arterial hypertension; GB5121 for adult patients with relapsed/refractory CNS lymphoma, and GB7208 for multiple sclerosis. The company is funded by Arch Venture Partners LP, Omega Fund Management LLC, and Hillhouse Capital Group. Gossamer Bio is headquartered in San Diego, California, the US.
-
Innovation Ranking
NewInnovation Ranking – Sesen Bio Inc
Carisma Therapeutics Inc (Carisma Therapeutics), formerly Sesen Bio Inc, is a late-stage clinical company that develops targeted fusion protein therapeutics (TFPTs) for the treatment of patients with cancer. The company’s TFPTs genetically combines targeting antibody fragments with cytotoxic protein payloads. Carisma Therapeutics' product pipeline includes Vicinium (VB4-845) also known as oportuzumab monatox, which is used for the treatment of high-grade non-muscle invasive bladder cancer(NMIBC). The company operates in the US, the UK, and Canada. Carisma Therapeutics is headquartered in Cambridge,...
-
Innovation Ranking
NewInnovation Ranking – BrightGene Bio-Medical Technology Co Ltd
BrightGene Bio-Medical Technology Co Ltd (BrightGene) is a biopharmaceutical company that manufacturing, research and develop of generic drugs. The company’s pipeline products include posaconazole, oseltamivir phosphate, orivancin, fidaxomycin, agatroban, fondaparinux, acarbose, iron supplements, trabectidine, pemetrexed disodium intermediate, eribulin mesylate, midotolin, everolimus and pimecrolimus, among others. Its veterinary drugs includes seramectin, telavancin hydrochloride, emodes, doramectin and dalbavancin. The company develops products in the therapeutic areas of cardiology, oncology, antibacterial, antifungal and veterinary. BrightGene is headquartered in Suzhou, Jiangsu, China.